Delocalization and Destabilization of the Arf Tumor Suppressor by the Leukemia-Associated NPM Mutant
Open Access
- 15 March 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 66 (6) , 3044-3050
Abstract
One third of acute myeloid leukemias (AMLs) are characterized by the aberrant cytoplasmic localization of nucleophosmin (NPM) due to mutations within its putative nucleolar localization signal. NPM mutations are mutually exclusive with major AML-associated chromosome rearrangements and are frequently associated with a normal karyotype, suggesting that they are critical during leukemogenesis. The underlying molecular mechanisms are, however, unknown. NPM is a nucleocytoplasmic shuttling protein that has been implicated in several cellular processes, including ribosome biogenesis, centrosome duplication, cell cycle progression, and stress response. It has been recently shown that NPM is required for the stabilization and proper nucleolar localization of the tumor suppressor p19Arf. We report here that the AML-associated NPM mutant localizes mainly in the cytoplasm due to an alteration of its nucleus-cytoplasmic shuttling equilibrium, forms a direct complex with p19Arf, but is unable to protect it from degradation. Consequently, cells or leukemic blasts expressing the NPM mutant have low levels of cytoplasmic Arf. Furthermore, we show that expression of the NPM mutant reduces the ability of Arf to initiate a p53 response and to induce cell cycle arrest. Inactivation of p19Arf, a key regulator of the p53-dependent cellular response to oncogene expression, might therefore contribute to leukemogenesis in AMLs with mutated NPM. (Cancer Res 2006; 66(6): 3044-50)Keywords
This publication has 25 references indexed in Scilit:
- Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signalOncogene, 2006
- Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemiaBlood, 2005
- Nucleophosmin Is Required for DNA Integrity and p19Arf Protein StabilityMolecular and Cellular Biology, 2005
- Nucleophosmin (B23) Targets ARF to Nucleoli and Inhibits Its FunctionMolecular and Cellular Biology, 2005
- Involvement of nucleophosmin/B23 in the response of HeLa cells to UV irradiationInternational Journal of Cancer, 2001
- The INK4a/ARF network in tumour suppressionNature Reviews Molecular Cell Biology, 2001
- Nucleolar protein B23 has molecular chaperone activitiesProtein Science, 1999
- Sedimentation Analyses of the Salt- and Divalent Metal Ion-Induced Oligomerization of Nucleolar Protein B23Biochemistry, 1996
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- Major nucleolar proteins shuttle between nucleus and cytoplasmCell, 1989